STRATA Skin Sciences Inc. (SSKN): Market Cap to Revenue

Symbol and logo of brand STRATA Skin (SSKN)

STRATA Skin Sciences (SSKN) is implementing ESG principles by optimizing laser energy consumption and packaging sustainability. The business model relies on recurring payments for each psoriasis treatment procedure performed by XTRAC systems. The current P/S multiple demonstrates the market valuation relative to revenue, where the value 0.00 captures this metric. Limited pricing power within the dermatology segment may constrain future profit growth.

SSKN STRATA Skin P/S Multiple (07/04/2022 - 02/21/2026)

Analytical breakdowns for STRATA Skin Sciences (SSKN)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:SSKN STRATA Skin Sciences Inc.
Core merchandise of STRATA Skin Sciences, Inc.

This price action reflects the market value's sensitivity to operational efficiency, measuring the price of every dollar of revenue through the ratio of market capitalization to annual sales. For STRATA Skin Sciences (SSKN), this calculation depends directly on the frequency of laser procedures and the US insurance reimbursement system, allowing the revenue multiple on the GURU.Markets platform to be assessed as an indicator of investment overheating.

Competitors of STRATA Skin Sciences

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|beyondair.net (XAIR) - Price-to-Revenue Ratio|PFSA - Price-to-Revenue Coefficient|Market Cap to Revenue GCTK|NAOV (nanovibronix.com) - Market Cap to Sales Volume|Price-to-Revenue Ratio Venus Concept Corp (VERO)|NUWE (Nuwellis Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AEMD (Aethlon Medical)|P/S Multiple Asensus Surgical Inc ASXC|AVGR: Market Cap to Revenue|BioSig - Market Cap to Sales Volume|CUTR: P/S Multiple|Know Labs Corporation (KNW) - P/S Multiple|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|Price-to-Revenue Coefficient Silk Road Medical, Inc.